Expert Forum on Cancer Diagnostics
The aim of this one-day forum is to exchange with experts on the future diagnostic landscape and on how this is going to impact cancer diagnosis and the definition of cancer.
Date | 06 - 07 Nov 2016 |
---|---|
Location | Centre for Global Dialogue Rüschlikon, Zurich, Switzerland Click to open Google Maps |
Tab navigation
Presentations
|
Sunday, 6 November 2016 |
18.30 |
Welcome dinner at Hotel Belvoir in Rüschlikon |
|
Monday, 7 November 2016 |
Event moderation: Christoph Nabholz, Head R&D Life&Health, Swiss Re |
|
08.00 |
Welcome coffee |
08.30 |
Welcome and introduction |
Session |
Cancer biomarker technologies |
08.35 |
The future of early molecular cancer diagnostics and preventive immunotherapy |
09.05 |
Liquid biopsies and the future of cancer detection |
09.20 |
Germline Genomics and Liquid Biopsies |
09.35 |
Advanced cancer diagnostics - a global market perspective |
09.50 |
Panel discussion moderated by Christoph Nabholz |
10.30 |
Coffee break |
11.00 |
Workshops Session 1: Breast cancer Session 2: Lung cancer Session 3: Colon cancer Session 4: Liver cancer |
12.00 |
Lunch |
Session |
Cancer imaging and data analytics |
13.15 |
Big pharma companion diagnostics and the future of preventive immunotherapy for early stage cancers |
13.30 |
Data-driven medicine revolution in oncology |
13.45 |
Early diagnostics of cancer through advanced imaging technology |
14.00 |
Cancer imaging in clinical practice |
14.15 |
Panel discussion moderated by John Schoonbee, Chief Medical Officer EMEA, Swiss Re |
15.00 |
Coffee break |
15.30 |
Workshops Session 1: Liquid biopsy Session 2: Imaging technology Session 3: Cancer profiling Session 4: Regulatory approval of cancer diagnostics |
16.30 |
Closing remarks and next steps |
16.45 |
End of event |
18.00 |
Optional networking dinner |